Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism - The Finnish Diabetes Prevention Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 9, 2011, Pages 691-698

  Lappalainen, T ^a   Kolehmainen, M ^a   Schwab, U S ^a,b   Tolppanen, A M ^a   Stancakova A ^b   Lindstrom J ^c,d   Eriksson, J G ^c,d,e   Keinanen Kiukaanniemi S ^f   Aunola, S ^c   Ilanne Parikka, P ^g   Herder, C ^h   Koenig, W ⁱ   Gylling, H ^a,b   Kolb, H ^a   Tuomilehto, J ^c,d   Kuusisto, J ^b   Uusitupa, M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

ⁱ UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cardiovascular disease; Finnish diabetes prevention study; FTO; Genetics; Obesity; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; FTO PROTEIN, HUMAN; PROTEIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; FINLAND; FOLLOW UP; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENOTYPE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS;

EID: 80052762427     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.01.006     Document Type: Article

References (33)

1. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
2. Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007, 3:e115.
3. Dina C., Meyre D., Gallina S., Durand E., Körner A., Jacobson P., et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Gene 2007, 39:724-726.
4. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
5. Lappalainen T.J., Tolppanen A.M., Kolehmainen M., Schwab U., Lindström J., Tuomilehto J., et al. The common variant in the FTO gene did not modify the effect of lifestyle changes on body weight - The Finnish Diabetes Prevention Study. Obesity 2009, 17:832-836.
6. Fisher E., Schulze M.B., Stefan N., Häring H.U., Döring F., Joost H.G., et al. Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity 2009, 17:330-334.
7. Freathy R.M., Timpson N.J., Lawlor D.A., Pouta A., Ben-Shlomo Y., Ruokonen A., et al. Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes 2008, 57:1419-1426.
8. von Hundelshausen P., Weber K.S., Huo Y., Proudfoot A.E., Nelson P.J., Ley K., et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001, 103:1772-1777.
9. Eriksson E.E. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects. Curr Opin Lipidol 2004, 15:553-558.
10. Skurk T., Mack I., Kempf K., Kolb H., Hauner H., Herder C. Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia. Horm Metab Res 2009, 41:183-189.
11. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
12. Lindström J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemiö K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679.
13. Eriksson J., Lindström J., Valle T., Aunola S., Hämäläinen H., Ilanne-Parikka P., et al. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia 1999, 42:793-801.
14. Herder C., Peltonen M., Koenig W., Kraft I., Muller-Scholze S., Martin S., et al. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes 2006, 55:2340-2346.
15. Uusitupa M., Peltonen M., Lindström J., Aunola S., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., et al. Ten - year mortality and cardiovascular morbidity in the finnish Diabetes Prevention Study - secondary analysis of the randomized trial. PLoS One 2009, 4:e5656.
16. Wang J., Kuusisto J., Vanttinen M., Kuulasmaa T., Lindstrom J., Tuomilehto J., et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia 2007, 50:1192-1200.
17. World Health Organization Definition, diagnosis and classification of diabetes: mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus 1999, Department of Noncommunicable Disease Surveillance, Geneva.
18. Doney A.S.F., Dannfald J., Kimber C.H., Donnelly L.A., Pearson E., Morris A.D., et al. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with Type 2 Diabetes: A Go-DARTS study. Circ Cardiovasc Genet 2009, March 30.
19. Zimmermann E., Kring S.I., Berentzen T.L., Holst C., Pers T.H., Hansen T., et al. Fatness-associated FTO gene variant increases mortality independent of fatness-in cohorts of Danish men. PLoS One 2009, 4:e4428.
20. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986, 111:383-390.
21. Wingard D.L., Suarez L., Barrett-Connor E. The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol 1983, 117:165-172.
22. Jacobsson J.A., Danielsson P., Svensson V., Klovins J., Gyllensten U., Marcus C., et al. Biochem Biophys Res Commun 2008, 368:476-482.
23. Kring S.I., Holst C., Zimmermann E., Jess T., Berentzen T., Toubro S., et al. FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS One 2008, 3:e2958.
24. Zabena C., González-Sánchez J.L., Martínez-Larrad M.T., Torres-García A., Alvarez-Fernández-Represa J., Corbatón-Anchuelo A., et al. The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes Surg 2009, 19:87-95.
25. Pausova Z., Syme C.A., Abarahamowicz M., Xiao Y., Leonard G.T., Perron M., et al. A common variant of the FTO gene is associated not only with increased adiposity but also elevated blood pressure in French-Canadians. Circ Cardiovasc Genet 2009, March 31.
26. Fischer J., Koch L., Emmerling C., Vierkotten J., Peters T., Brüning J.C., et al. Inactivation of the FTO gene protects from obesity. Nature 2009, 458:894-898.
27. Cecil J.E., Tavendale R., Watt P., Hetherington M.M., Palmer C.N. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 2008, 359:2558-2566.
28. Timpson N.J., Emmett P.M., Frayling T.M., Rogers I., Hattersley A.T., McCarthy M.I., et al. The fat mass- and obesity-associated locus and dietary intake in children. Am J Clin Nutr 2008, 88:971-978.
29. Wardle J., Llewellyn C., Sanderson S., Plomin R. The FTO gene and measured food intake in children. Int J Obes 2009, 33:42-45.
30. Wardle J., Carnell S., Haworth C.M., Farooqi I.S., O'Rahilly S., Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 2008, 93:3640-3643.
31. Samani N.J., Erdmann J., Hall A.S., Hengstenberg C., Mangino M., Mayer B., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 2007, 357:497-499.
32. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D.R., et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007, 316:1488-1491.
33. Erdmann J., Grosshennig A., Braund P.S., König I.R., Hengstenberg C., Hall A.S., et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009, 41:280-282.